|August 5, 2015 Edition||
Welcome to Press Release 365!
Login | Register | FAQs | Contact
Revolutionary Study May Help Discover A Cure For Macular Degeneration
Feb 04, 2008
HUNTINGTON, NY -- Macular degeneration sufferers rejoice: researchers are one step closer to finding a cure for the swift and permanent eye disease. The Cleveland Clinic Lerner College of Medicine recently sponsored a study called the "Oxidative damage-induced inflammation initiates age-related macular degeneration". The study was published in Nature Medicine, a medical journal.
The intent of the study was to develop an "animal model" to show the path of age-related macular degeneration. By using oxidative chemicals, the team of researchers weakened the immune system in mice and created macular degeneration. They will test possible macular degeneration cures and treatments on the mice in an effort to find a cure for macular degeneration in humans.
Over nine million Americans suffer from age-related macular degeneration, and a cure or powerful treatment will dramatically improve the lives of macular degeneration sufferers. Currently, one of the major macular degeneration treatments involves the National Eye Institute's Age Related Eye Disease Study (AREDS). AREDS showed that taking certain doses of Anti-Oxidants and Zinc can slow the progression of macular degeneration by up to 25%. Macular degeneration vitamins duplicating the ingredients in AREDS have also shown to be effective.
In the article "Study Paves Way For Development Of Macular Degeneration Cures" in Science Daily, Stephen Rose, Ph.D., Chief Research Officer for the Foundation Fighting Blindness, explains how the new "animal model" can help macular degeneration patients.
"Though there are some treatments for the wet form of AMD, we still don't have a cure for the condition, and millions of people are still at risk of losing their vision to both the dry and wet forms. This new model will greatly enhance the development of better treatments and potentially a cure," says Rose.
Dr. Paul Krawitz, of VisiVite.com, is on a panel of ophthalmologists dedicated to creating effective macular degeneration supplements to help people maintain healthy vision for life.
"Oxidative compounds are highly destructive," said Dr. Krawitz, "causing both age related diseases, such as macular degeneration, as well as many cancers. The Cleveland Clinic study provides further support of the need for taking specific nutritional supplements that contain vitamins and minerals that have been shown to reduce or eliminate the damaging effects of these volatile oxidative molecules."
VisiVite.com was founded in 2001 and is dedicated to providing customers with state of the art macular degeneration vitamins to lessen the risk of age related macular degeneration. Their products range from the VisiVite AREDS Formula and Macular Degeneration Vitamins to Dry Eye Relief Vitamins, and AMD Eye Multivitamins. For more information and up to the minute AMD news, visit VisiVite.com.
Keywords: macular degeneration vitamins, eye supplements, amd supplements Medical » Vision Eye Care
Press Release Services